Top 10 Companies in the Global Dental Bioactive Glass Market (2026): Market Leaders Powering Advanced Dentistry

MARKET INSIGHTS

Global dental bioactive glass market size was valued at USD 312.5 million in 2024. The market is projected to grow from USD 342.7 million in 2025 to USD 598.4 million by 2032, exhibiting a CAGR of 7.2% during the forecast period.

Dental bioactive glass refers to specialized biocompatible materials that chemically bond with bone and soft tissues, promoting regeneration in dental applications. These glass compositions, primarily silicate‑based, release therapeutic ions such as calcium and phosphate that stimulate natural tissue repair. They are widely used in procedures including bone grafts, periodontal treatments, and preventive dentistry due to their osteoconductive and antimicrobial properties.

The market growth is driven by increasing prevalence of dental disorders globally, with over 3.5 billion people affected by oral diseases according to WHO data. Rising adoption of bioactive materials in minimally invasive dentistry and technological advancements in glass formulations are accelerating market expansion. Key players such as SCHOTT AG and NovaBone are investing heavily in R&D, with recent product launches focusing on enhanced bioactivity and handling properties for clinical applications.

Global Dental Bioactive Glass Market – View in Detailed Research Report

🔟 1. SCHOTT AG

Headquarters: Jena, Germany
Key Offering: High‑purity 4555 Bioglass® and advanced bioactive glass formulations

SCHOTT AG has long dominated the glass industry with a focus on precision chemistry. Its 4555 Bioglass® platform delivers rapid hydroxyapatite formation and has become the benchmark for clinical success in bone grafting and periodontal regeneration. The company’s recent portfolio expansion includes injectable putties and composite blends that simplify handling for dental practitioners.

Sustainability & Growth Initiatives:

• Investment in sol‑gel synthesis to reduce energy consumption and material waste
• Collaboration with universities on nanostructured glass to enhance bioactivity
• Commitment to carbon‑neutral manufacturing by 2030

9️⃣ 2. NovaBone Products LLC

Headquarters: Chicago, USA
Key Offering: Bioactive glass bone graft substitutes and regenerative composites

NovaBone’s flagship product, NovaBone® Bioglass®, is engineered for high‑density bone regeneration with a controlled ion release profile. The company has recently introduced a light‑curable composite that integrates seamlessly with resin‑based restorations, reducing operative time.

Sustainability & Growth Initiatives:

• Closed‑loop recycling of glass powders to minimize raw material intake
• Partnerships with dental schools to validate clinical protocols
• Expansion into emerging markets with cost‑effective formulations

8️⃣ 3. Mo‑Sci Corporation

Headquarters: Irvine, USA
Key Offering: Advanced bioactive glass powders and custom‑tailored ion‑release systems

Mo‑Sci’s portfolio includes a line of boron‑doped glasses that accelerate hydroxyapatite deposition, making them attractive for periodontal defect repair. The firm’s focus on modular formulations allows clinicians to adjust viscosity for different clinical scenarios.

Sustainability & Growth Initiatives:

• Development of low‑temperature sintering processes to cut CO₂ emissions
• Strategic alliances with implant manufacturers for surface coatings
• Investment in digital dentistry workflows for customized restorations

7️⃣ 4. Ferro Corporation

Headquarters: Phoenix, USA
Key Offering: Functional coatings and specialty bioactive glass for medical devices

Ferro leverages its expertise in coating technologies to deliver bioactive glass layers that promote osseointegration on titanium implants. The company’s recent launch of a hybrid glass‑polymer composite offers both mechanical strength and bioactivity for load‑bearing applications.

Sustainability & Growth Initiatives:

• Adoption of renewable energy sources in production facilities
• Research into biodegradable glass matrices for temporary scaffolds
• Engagement with regulatory bodies to streamline approval pathways

6️⃣ 5. Matexcel

Headquarters: Austin, USA
Key Offering: High‑purity research‑grade bioactive glass and custom formulations

Matexcel supplies the scientific community with glass powders that meet the strictest purity standards, enabling researchers to develop next‑generation biomaterials. The firm’s recent focus on tailoring ion release kinetics has attracted collaborations with academic institutions.

Sustainability & Growth Initiatives:

• Implementation of waste‑heat recovery systems in manufacturing
• Support for open‑access research to accelerate innovation
• Expansion of distribution networks in Asia‑Pacific

5️⃣ 6. BioActive International

Headquarters: Zurich, Switzerland
Key Offering: Antimicrobial bioactive glass for restorative and preventive applications

BioActive International has pioneered silver‑doped glass formulations that reduce bacterial colonization by over 90 %. The company’s products are marketed to dentists seeking to prevent secondary caries and peri‑implantitis.

Sustainability & Growth Initiatives:

• Development of non‑antibiotic antimicrobial strategies
• Collaboration with dental product manufacturers for integrated solutions
• Focus on green chemistry in glass synthesis

4️⃣ 7. Dental Glass Innovations

Headquarters: Toronto, Canada
Key Offering: Bioactive glass composites for aesthetic restorations

The firm offers a line of tooth‑like glass composites that match the optical properties of natural dentition. These materials are designed for use in anterior restorations and cosmetic dentistry, meeting the demand for natural‑appearing solutions.

Sustainability & Growth Initiatives:

• Use of recycled glass feedstock in production
• Research into biodegradable resin matrices
• Partnerships with dental schools for clinical trials

3️⃣ 8. VITA Dental Technologies

Headquarters: Stuttgart, Germany
Key Offering: Bioactive glass–based restorative materials and impression systems

VITA’s bioactive glass products are integrated into its existing line of restorative materials, offering clinicians a single‑step solution that promotes remineralization while restoring function.

Sustainability & Growth Initiatives:

• Carbon‑neutral production lines by 2028
• Investment in digital dentistry integration for customized fittings
• Active engagement in global oral health awareness campaigns

2️⃣ 9. NANO Bio

Headquarters: Singapore
Key Offering: Nanoscale bioactive glass particles for targeted delivery

NANO Bio’s nanostructured glass releases ions at a controlled rate, enhancing bone regeneration in critical‑size defects. The company’s products are positioned for both dental and orthopedic markets.

Sustainability & Growth Initiatives:

• Use of renewable feedstocks for glass synthesis
• Collaborations with implant manufacturers for surface functionalization
• Development of eco‑friendly packaging solutions

1️⃣ 10. Dental Glass Solutions Ltd.

Headquarters: London, United Kingdom
Key Offering: Customizable bioactive glass formulations for regenerative dentistry

The firm offers a modular platform that allows clinicians to select glass composition based on defect size, load requirements, and desired resorption rate. This flexibility has positioned Dental Glass Solutions as a preferred partner for complex cases.

Sustainability & Growth Initiatives:

• Closed‑loop recycling of glass waste
• Investment in digital manufacturing for precision dosing
• Strategic alliances with European dental associations to drive adoption

Global Dental Bioactive Glass Market – View in Detailed Research Report

Global Dental Bioactive Glass Market – View in Detailed Research Report

Outlook

Over the next decade, the dental bioactive glass market will continue to expand as clinicians adopt materials that deliver both therapeutic benefits and aesthetic appeal. The convergence of advanced glass chemistry with digital dentistry tools—such as 3D printing and CAD/CAM workflows—will enable fully customized, bioactive restorations that meet patient‑specific anatomical and functional requirements. Regulatory frameworks are evolving to accommodate novel bioactive formulations, reducing approval timelines and encouraging innovation.

Future Trends

• Development of multi‑functional glasses that combine bioactivity with drug delivery for localized therapy.
• Integration of bioactive glass into implant surface coatings to reduce peri‑implantitis and improve osseointegration.
• Expansion of antimicrobial glass formulations to address rising concerns over antibiotic resistance.
• Adoption of digital manufacturing and AI‑driven design tools to produce patient‑specific glass composites.
• Growth of cost‑effective glass solutions tailored for emerging markets, driven by local manufacturing and strategic partnerships.